UnitedHealth Group Incorporated $UNH Stake Lessened by Premier Path Wealth Partners LLC

Premier Path Wealth Partners LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 24.8% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,924 shares of the healthcare conglomerate’s stock after selling 1,295 shares during the period. Premier Path Wealth Partners LLC’s holdings in UnitedHealth Group were worth $1,224,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Bayforest Capital Ltd raised its holdings in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its stake in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. Glass Jacobson Investment Advisors llc grew its stake in UnitedHealth Group by 80.9% in the second quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock valued at $38,000 after purchasing an additional 55 shares in the last quarter. Kentucky Trust Co grew its stake in UnitedHealth Group by 53.8% in the second quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after purchasing an additional 50 shares in the last quarter. Finally, O Brien Wealth Partners LLC grew its stake in UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after purchasing an additional 37 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 3.0%

UnitedHealth Group stock opened at $344.57 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The business’s 50-day simple moving average is $342.82 and its 200-day simple moving average is $331.10. The firm has a market capitalization of $312.07 billion, a PE ratio of 17.98, a PEG ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same period in the previous year, the company posted $7.15 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.6%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 46.14%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent research reports. Weiss Ratings upgraded UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. Bank of America increased their target price on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 8th. Barclays increased their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a research report on Thursday, October 9th. Oppenheimer lowered their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Finally, Robert W. Baird reissued an “underperform” rating and set a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.